|
|
Blood, Vol. 111, Issue 11, 5342-5349, June 1, 2008
Development and dynamics of robust T-cell responses to CML under imatinib treatment
Blood Chen et al.
111: 5342
Supplemental materials for: Chen et al
Files in this Data Supplement:
- Figure S1. No anti-leukemia T cell responses in 5 patients (JPG, 31.8 KB)
-
Anti-leukemia immune response in 5 of 14 patients via IFN- ELISPOT assay. Leukemic cells alone (white), remission sample alone (grey), leukemic and remission samples black). The following stimulated remission samples from the patients are shown and depicted as median and range: P5 – 6, 10, 24, 36 months, P7 – 10 months, P9 –16 months, P10 – 3, 4, 6, 24, 27, 40 months, P14 – 1, 3, 5 months. All responses were statistically not significant (p>0.05) as compared with leukemic or remission samples alone.
|
|
